The DOI matches its Crossref record; 164 of the 164 references it cites were found in a registry or an index.
Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses
Open accessAbstract
Seven coronaviruses (CoVs) have been isolated from humans so far. Among them, three emerging pathogenic CoVs, including severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV), and a newly identified CoV (2019-nCoV), once caused or continue to cause severe infections in humans, posing significant threats to global public health. SARS-CoV infection in humans (with about 10% case fatality rate) was first reported from China in 2002, while MERS-CoV infection in humans (with about 34.4% case fatality rate) was first reported from Saudi Arabia in June 2012. 2019-nCoV was first reported from China in December 2019, and is currently infecting more than twenty thousand people (with about 2.1% case fatality rate). Both SARS-CoV and MERS-CoV are zoonotic viruses, using bats as their natural reservoirs, and then transmitting through intermediate hosts, leading to human infections. Nevertheless, the intermediate host for 2019-nCoV is still under investigation and the vaccines against this new CoV have not been available. Although a variety of vaccines have been developed against infections of SARS-CoV and MERS-CoV, none of them has been approved for use in humans. In this review, we have described the structure and function of key proteins of emerging human CoVs, overviewed the current vaccine types to be developed against SARS-CoV and MERS-CoV, and summarized recent advances in subunit vaccines against these two pathogenic human CoVs. These subunit vaccines are introduced on the basis of full-length spike (S) protein, receptor-binding domain (RBD), non-RBD S protein fragments, and non-S structural proteins, and the potential factors affecting these subunit vaccines are also illustrated. Overall, this review will be helpful for rapid design and development of vaccines against the new 2019-nCoV and any future CoVs with pandemic potential. This review was written for the topic of Antivirals for Emerging Viruses: Vaccines and Therapeutics in the Virology section of Frontiers in Microbiology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Woo, P. C. Y., Lau, S. K. P., Lam, C. S. F., et al. (2013) · Journal of Virology · doi:10.1128/jvi.02351-13 · Cited by 154
RetractedA novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923
Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211721 · Cited by 5,735
Origin and evolution of pathogenic coronaviruses
Cui, J., Li, F., & Shi, Z.-L. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0118-9 · Cited by 5,515
Identification of a novel coronavirus in patients with severe acute respiratory syndrome
Drosten, C., Günther, S., Preiser, W., van der Werf, S., Brodt, H.-R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030747 · Cited by 4,574
A Novel Coronavirus Associated with Severe Acute Respiratory Syndrome
Ksiazek, T. G., Erdman, D., Goldsmith, C. S., Zaki, S. R., Peret, T., Emery, S., Tong, S., Urbani, C., Comer, J. A., Lim, W., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030781 · Cited by 4,344
Coronaviruses: An Overview of Their Replication and Pathogenesis
Fehr, A. R., & Perlman, S. (2015) · Methods in Molecular Biology · doi:10.1007/978-1-4939-2438-7_1 · Cited by 3,787
Structure, Function, and Evolution of Coronavirus Spike Proteins
Li, F. (2016) · Annual Review of Virology · doi:10.1146/annurev-virology-110615-042301 · Cited by 2,740
Bats Are Natural Reservoirs of SARS-Like Coronaviruses
Li, W., Shi, Z., Yu, M., Ren, W., Smith, C., Epstein, J. H., Wang, H., Crameri, G., Hu, Z., Zhang, H., et al. (2005) · Science · doi:10.1126/science.1118391 · Cited by 2,560
Channappanavar, R., & Perlman, S. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0629-x · Cited by 2,524
Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome
Rota, P. A., Oberste, M. S., Monroe, S. S., Nix, W. A., Campagnoli, R., Icenogle, J. P., Peñaranda, S., Bankamp, B., Maher, K., Chen, M.-H., et al. (2003) · Science · doi:10.1126/science.1085952 · Cited by 2,474
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
Raj, V. S., Mou, H., Smits, S. L., Dekkers, D. H. W., Müller, M. A., Dijkman, R., Muth, D., Demmers, J. A. A., Zaki, A., Fouchier, R. A. M., et al. (2013) · Nature · doi:10.1038/nature12005 · Cited by 2,061
Structure of SARS Coronavirus Spike Receptor-Binding Domain Complexed with Receptor
Li, F., Li, W., Farzan, M., & Harrison, S. C. (2005) · Science · doi:10.1126/science.1116480 · Cited by 2,031
The Genome Sequence of the SARS-Associated Coronavirus
Marra, M. A., Jones, S. J. M., Astell, C. R., Holt, R. A., Brooks-Wilson, A., Butterfield, Y. S. N., Khattra, J., Asano, J. K., Barber, S. A., Chan, S. Y., et al. (2003) · Science · doi:10.1126/science.1085953 · Cited by 2,026
Identification of a new human coronavirus
van der Hoek, L., Pyrc, K., Jebbink, M. F., Vermeulen-Oost, W., Berkhout, R. J. M., Wolthers, K. C., Wertheim-van Dillen, P. M. E., Kaandorp, J., Spaargaren, J., & Berkhout, B. (2004) · Nature Medicine · doi:10.1038/nm1024 · Cited by 1,886
Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor
Ge, X.-Y., Li, J.-L., Yang, X.-L., Chmura, A. A., Zhu, G., Epstein, J. H., Mazet, J. K., Hu, B., Zhang, W., Peng, C., et al. (2013) · Nature · doi:10.1038/nature12711 · Cited by 1,778
Self-citationWoo, P. C. Y., Lau, S. K. P., Lam, C. S. F., Lau, C. C. Y., Tsang, A. K. L., Lau, J. H. N., Bai, R., Teng, J. L. L., Tsang, C. C. C., Wang, M., et al. (2012) · Journal of Virology · doi:10.1128/jvi.06540-11 · Cited by 1,677
The spike protein of SARS-CoV — a target for vaccine and therapeutic development
Du, L., He, Y., Zhou, Y., Liu, S., Zheng, B.-J., & Jiang, S. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2090 · Cited by 1,661
Self-citationZhong, N., Zheng, B., Li, Y., Poon, L., Xie, Z., Chan, K., Li, P., Tan, S., Chang, Q., Xie, J., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14630-2 · Cited by 1,579
Woo, P. C. Y., Lau, S. K. P., Chu, C.-M., Chan, K.-H., Tsoi, H.-W., Huang, Y., Wong, B. H. L., Poon, R. W. S., Cai, J. J., Luk, W.-K., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.2.884-895.2005 · Cited by 1,525
Snijder, E. J., Bredenbeek, P. J., Dobbe, J. C., Thiel, V., Ziebuhr, J., Poon, L. L. M., Guan, Y., Rozanov, M., Spaan, W. J. M., & Gorbalenya, A. E. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00865-9 · Cited by 1,198
King, A. M. Q., Lefkowitz, E. J., Mushegian, A. R., Adams, M. J., Dutilh, B. E., Gorbalenya, A. E., Harrach, B., Harrison, R. L., Junglen, S., Knowles, N. J., et al. (2018) · Archives of Virology · doi:10.1007/s00705-018-3847-1 · Cited by 1,078
Lung pathology of fatal severe acute respiratory syndrome
Nicholls, J. M., Poon, L. L., Lee, K. C., Ng, W. F., Lai, S. T., Leung, C. Y., Chu, C. M., Hui, P. K., Mak, K. L., Lim, W., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13413-7 · Cited by 1,076
Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen
Pallesen, J., Wang, N., Corbett, K. S., Wrapp, D., Kirchdoerfer, R. N., Turner, H. L., Cottrell, C. A., Becker, M. M., Wang, L., Shi, W., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1707304114 · Cited by 1,073
Self-citationReceptor and viral determinants of SARS‐coronavirus adaptation to human ACE2
Li, W., Zhang, C., Sui, J., Kuhn, J. H., Moore, M. J., Luo, S., Wong, S., Huang, I., Xu, K., Vasilieva, N., et al. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600640 · Cited by 988
Hu, B., Zeng, L.-P., Yang, X.-L., Ge, X.-Y., Zhang, W., Li, B., Xie, J.-Z., Shen, X.-R., Zhang, Y.-Z., Wang, N., et al. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006698 · Cited by 950
Self-citationvan Boheemen, S., de Graaf, M., Lauber, C., Bestebroer, T. M., Raj, V. S., Zaki, A. M., Osterhaus, A. D. M. E., Haagmans, B. L., Gorbalenya, A. E., Snijder, E. J., et al. (2012) · mBio · doi:10.1128/mbio.00473-12 · Cited by 914
Evidence for Camel-to-Human Transmission of MERS Coronavirus
Azhar, E. I., El-Kafrawy, S. A., Farraj, S. A., Hassan, A. M., Al-Saeed, M. S., Hashem, A. M., & Madani, T. A. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1401505 · Cited by 905
A New Virus Isolated from the Human Respiratory Tract.
Hamre, D., & Procknow, J. J. (1966) · Experimental Biology and Medicine · doi:10.3181/00379727-121-30734 · Cited by 884
Hofmann, H., Pyrc, K., van der Hoek, L., Geier, M., Berkhout, B., & Pöhlmann, S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409465102 · Cited by 824
Yuan, Y., Cao, D., Zhang, Y., Ma, J., Qi, J., Wang, Q., Lu, G., Wu, Y., Yan, J., Shi, Y., et al. (2017) · Nature Communications · doi:10.1038/ncomms15092 · Cited by 760
Immune response, inflammation, and the clinical spectrum of COVID-19
García, L. F. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01441 · Cited by 739
Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26
Lu, G., Hu, Y., Wang, Q., Qi, J., Gao, F., Li, Y., Zhang, Y., Zhang, W., Yuan, Y., Bao, J., et al. (2013) · Nature · doi:10.1038/nature12328 · Cited by 739
Reusken, C. B., Haagmans, B. L., Müller, M. A., Gutierrez, C., Godeke, G.-J., Meyer, B., Muth, D., Raj, V. S., Vries, L. S.-D., Corman, V. M., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70164-6 · Cited by 734
Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4
Wang, N., Shi, X., Jiang, L., Zhang, S., Wang, D., Tong, P., Guo, D., Fu, L., Cui, Y., Liu, X., et al. (2013) · Cell Research · doi:10.1038/cr.2013.92 · Cited by 719
Self-citationWong, S. K., Li, W., Moore, M. J., Choe, H., & Farzan, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c300520200 · Cited by 694
A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice
Yang, Z.-Y., Kong, W.-P., Huang, Y., Roberts, A., Murphy, B. R., Subbarao, K., & Nabel, G. J. (2004) · Nature · doi:10.1038/nature02463 · Cited by 665
Cultivation of a Novel Type of Common-cold Virus in Organ Cultures
Tyrrell, D. A. J., & Bynoe, M. L. (1965) · BMJ · doi:10.1136/bmj.1.5448.1467 · Cited by 621
A previously undescribed coronavirus associated with respiratory disease in humans
Fouchier, R. A. M., Hartwig, N. G., Bestebroer, T. M., Niemeyer, B., de Jong, J. C., Simon, J. H., & Osterhaus, A. D. M. E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400762101 · Cited by 598
Receptor Recognition Mechanisms of Coronaviruses: a Decade of Structural Studies
Li, F. (2015) · Journal of Virology · doi:10.1128/jvi.02615-14 · Cited by 573
Structural basis for human coronavirus attachment to sialic acid receptors
Tortorici, M. A., Walls, A. C., Lang, Y., Wang, C., Li, Z., Koerhuis, D., Boons, G.-J., Bosch, B.-J., Rey, F. A., de Groot, R. J., et al. (2019) · Nature Structural & Molecular Biology · doi:10.1038/s41594-019-0233-y · Cited by 569
The Nonstructural Proteins Directing Coronavirus RNA Synthesis and Processing
Snijder, E. J., Decroly, E., & Ziebuhr, J. (2016) · Advances in Virus Research · doi:10.1016/bs.aivir.2016.08.008 · Cited by 558
Recent advances in the detection of respiratory virus infection in humans
Zhang, N., Wang, L., Deng, X., Liang, R., Su, M., He, C., Hu, L., Su, Y., Ren, J., Yu, F., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25674 · Cited by 550
Self-citationNeuroinvasion by Human Respiratory Coronaviruses
Arbour, N., Day, R., Newcombe, J., & Talbot, P. J. (2000) · Journal of Virology · doi:10.1128/jvi.74.19.8913-8921.2000 · Cited by 522
Coronavirus HKU1 and Other Coronavirus Infections in Hong Kong
Lau, S. K. P., Woo, P. C. Y., Yip, C. C. Y., Tse, H., Tsoi, H.-W., Cheng, V. C. C., Lee, P., Tang, B. S. F., Cheung, C. H. Y., Lee, R. A., et al. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.02614-05 · Cited by 442
Accessory proteins of SARS-CoV and other coronaviruses
Liu, D. X., Fung, T. S., Chong, K. K.-L., Shukla, A., & Hilgenfeld, R. (2014) · Antiviral Research · doi:10.1016/j.antiviral.2014.06.013 · Cited by 431
Bisht, H., Roberts, A., Vogel, L., Bukreyev, A., Collins, P. L., Murphy, B. R., Subbarao, K., & Moss, B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401939101 · Cited by 420
Ecology, evolution and classification of bat coronaviruses in the aftermath of SARS
Drexler, J. F., Corman, V. M., & Drosten, C. (2014) · Antiviral Research · doi:10.1016/j.antiviral.2013.10.013 · Cited by 406
He, Y., Zhou, Y., Liu, S., Kou, Z., Li, W., Farzan, M., & Jiang, S. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.09.106 · Cited by 403
Self-citationIdentification of a Novel Coronavirus in Bats
Poon, L. L. M., Chu, D. K. W., Chan, K. H., Wong, O. K., Ellis, T. M., Leung, Y. H. C., Lau, S. K. P., Woo, P. C. Y., Suen, K. Y., Yuen, K. Y., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.4.2001-2009.2005 · Cited by 397
Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor
Lu, L., Liu, Q., Zhu, Y., Chan, K.-H., Qin, L., Li, Y., Wang, Q., Chan, J. F.-W., Du, L., Yu, F., et al. (2014) · Nature Communications · doi:10.1038/ncomms4067 · Cited by 388
Self-citationBuchholz, U. J., Bukreyev, A., Yang, L., Lamirande, E. W., Murphy, B. R., Subbarao, K., & Collins, P. L. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403492101 · Cited by 385
Hulswit, R. J. G., Lang, Y., Bakkers, M. J. G., Li, W., Li, Z., Schouten, A., Ophorst, B., van Kuppeveld, F. J. M., Boons, G.-J., Bosch, B.-J., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1809667116 · Cited by 380
Human Betacoronavirus 2c EMC/2012–related Viruses in Bats, Ghana and Europe
Annan, A., Baldwin, H. J., Corman, V. M., Klose, S. M., Owusu, M., Nkrumah, E. E., Badu, E. K., Anti, P., Agbenyega, O., Meyer, B., et al. (2013) · Emerging Infectious Diseases · doi:10.3201/eid1903.121503 · Cited by 376
Jiang, S., Du, L., & Shi, Z. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1723441 · Cited by 330
Self-citationLi, W., Hulswit, R. J. G., Widjaja, I., Raj, V. S., McBride, R., Peng, W., Widagdo, W., Tortorici, M. A., van Dieren, B., Lang, Y., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1712592114 · Cited by 327
Chiu, S. S., Hung Chan, K., Wing Chu, K., Kwan, S. W., Guan, Y., Man Poon, L. L., & Peiris, J. S. M. (2005) · Clinical Infectious Diseases · doi:10.1086/430301 · Cited by 325
MERS-CoV spike protein: a key target for antivirals
Du, L., Yang, Y., Zhou, Y., Lu, L., Li, F., & Jiang, S. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1271415 · Cited by 301
Evaluation of candidate vaccine approaches for MERS-CoV
Wang, L., Shi, W., Joyce, M. G., Modjarrad, K., Zhang, Y., Leung, K., Lees, C. R., Zhou, T., Yassine, H. M., Kanekiyo, M., et al. (2015) · Nature Communications · doi:10.1038/ncomms8712 · Cited by 299
Human coronavirus circulation in the United States 2014–2017
Killerby, M. E., Biggs, H. M., Haynes, A., Dahl, R. M., Mustaquim, D., Gerber, S. I., & Watson, J. T. (2018) · Journal of Clinical Virology · doi:10.1016/j.jcv.2018.01.019 · Cited by 298
Scobey, T., Yount, B. L., Sims, A. C., Donaldson, E. F., Agnihothram, S. S., Menachery, V. D., Graham, R. L., Swanstrom, J., Bove, P. F., Kim, J. D., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1311542110 · Cited by 283
Desforges, M., Le Coupanec, A., Brison, É., Meessen-Pinard, M., & Talbot, P. J. (2014) · Advances in Experimental Medicine and Biology · doi:10.1007/978-81-322-1777-0_6 · Cited by 281
Yang, Y., Du, L., Liu, C., Wang, L., Ma, C., Tang, J., Baric, R. S., Jiang, S., & Li, F. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1405889111 · Cited by 281
Self-citationMcIntosh, K., Becker, W. B., & Chanock, R. M. (1967) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.58.6.2268 · Cited by 277
Huang, X., Dong, W., Milewska, A., Golda, A., Qi, Y., Zhu, Q. K., Marasco, W. A., Baric, R. S., Sims, A. C., Pyrc, K., et al. (2015) · Journal of Virology · doi:10.1128/jvi.00854-15 · Cited by 261
Origin, Evolution, and Virulence of Porcine Deltacoronaviruses in the United States
Ma, Y., Zhang, Y., Liang, X., Lou, F., Oglesbee, M., Krakowka, S., & Li, J. (2015) · mBio · doi:10.1128/mbio.00064-15 · Cited by 261
An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels
Haagmans, B. L., van den Brand, J. M. A., Raj, V. S., Volz, A., Wohlsein, P., Smits, S. L., Schipper, D., Bestebroer, T. M., Okba, N., Fux, R., et al. (2016) · Science · doi:10.1126/science.aad1283 · Cited by 259
Woo, P. C. Y., Lau, S. K. P., Lam, C. S. F., Lai, K. K. Y., Huang, Y., Lee, P., Luk, G. S. M., Dyrting, K. C., Chan, K.-H., & Yuen, K.-Y. (2009) · Journal of Virology · doi:10.1128/jvi.01977-08 · Cited by 257
Bukreyev, A., Lamirande, E. W., Buchholz, U. J., Vogel, L. N., Elkins, W. R., Claire, M. S., Murphy, B. R., Subbarao, K., & Collins, P. L. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16501-x · Cited by 256
An Outbreak of Coronavirus OC43 Respiratory Infection in Normandy, France
Vabret, A., Mourez, T., Gouarin, S., Petitjean, J., & Freymuth, F. (2003) · Clinical Infectious Diseases · doi:10.1086/374222 · Cited by 248
An update on feline infectious peritonitis: Virology and immunopathogenesis
Pedersen, N. C. (2014) · The Veterinary Journal · doi:10.1016/j.tvjl.2014.04.017 · Cited by 245
He, Y., Lu, H., Siddiqui, P., Zhou, Y., & Jiang, S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.8.4908 · Cited by 241
Self-citationMou, H., Raj, V. S., van Kuppeveld, F. J. M., Rottier, P. J. M., Haagmans, B. L., & Bosch, B. J. (2013) · Journal of Virology · doi:10.1128/jvi.01277-13 · Cited by 241
Antibodies to SARS Coronavirus in Civets
Tu, C., Crameri, G., Kong, X., Chen, J., Sun, Y., Yu, M., Xiang, H., Xia, X., Liu, S., Ren, T., et al. (2004) · Emerging Infectious Diseases · doi:10.3201/eid1012.040520 · Cited by 240
Jiang, S., He, Y., & Liu, S. (2005) · Emerging Infectious Diseases · doi:10.3201/1107.050219 · Cited by 215
Self-citationKam, Y. W., Kien, F., Roberts, A., Cheung, Y. C., Lamirande, E. W., Vogel, L., Chu, S. L., Tse, J., Guarner, J., Zaki, S. R., et al. (2007) · Vaccine · doi:10.1016/j.vaccine.2006.08.011 · Cited by 210
Rhinovirus and Coronavirus Infection–Associated Hospitalizations among Older Adults
Falsey, A. R., Walsh, E. E., & Hayden, F. G. (2002) · The Journal of Infectious Diseases · doi:10.1086/339881 · Cited by 194
Pimentel, T. A. P. F., Yan, Z., Jeffers, S. A., Holmes, K. V., Hodges, R. S., & Burkhard, P. (2009) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2008.00746.x · Cited by 182
Du, L., Zhao, G., He, Y., Guo, Y., Zheng, B.-J., Jiang, S., & Zhou, Y. (2007) · Vaccine · doi:10.1016/j.vaccine.2006.10.031 · Cited by 182
Self-citationLi, F. (2008) · Journal of Virology · doi:10.1128/jvi.00442-08 · Cited by 181
Du, L., Zhao, G., Kou, Z., Ma, C., Sun, S., Poon, V. K. M., Lu, L., Wang, L., Debnath, A. K., Zheng, B.-J., et al. (2013) · Journal of Virology · doi:10.1128/jvi.01048-13 · Cited by 178
Self-citationCoronavirus virulence genes with main focus on SARS-CoV envelope gene
DeDiego, M. L., Nieto-Torres, J. L., Jimenez-Guardeño, J. M., Regla-Nava, J. A., Castaño-Rodriguez, C., Fernandez-Delgado, R., Usera, F., & Enjuanes, L. (2014) · Virus Research · doi:10.1016/j.virusres.2014.07.024 · Cited by 177
Elshabrawy, H. A., Coughlin, M. M., Baker, S. C., & Prabhakar, B. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050366 · Cited by 172
Gerna, G., Campanini, G., Rovida, F., Percivalle, E., Sarasini, A., Marchi, A., & Baldanti, F. (2006) · Journal of Medical Virology · doi:10.1002/jmv.20645 · Cited by 172
Li, W., Greenough, T. C., Moore, M. J., Vasilieva, N., Somasundaran, M., Sullivan, J. L., Farzan, M., & Choe, H. (2004) · Journal of Virology · doi:10.1128/jvi.78.20.11429-11433.2004 · Cited by 171
Tomar, S., Johnston, M. L., St. John, S. E., Osswald, H. L., Nyalapatla, P. R., Paul, L. N., Ghosh, A. K., Denison, M. R., & Mesecar, A. D. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.651463 · Cited by 164
Du, L., Kou, Z., Ma, C., Tao, X., Wang, L., Zhao, G., Chen, Y.-Q., Yu, F., Tseng, C.-T. K., Zhou, Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081587 · Cited by 162
Self-citationCurrent advancements and potential strategies in the development of MERS-CoV vaccines
Zhang, N., Jiang, S., & Du, L. (2014) · Expert Review of Vaccines · doi:10.1586/14760584.2014.912134 · Cited by 158
Self-citationLuo, C.-M., Wang, N., Yang, X., Liu, H.-Z., Zhang, W., Li, B., Hu, B., Peng, C., Geng, Q.-B., Zhu, G.-J., et al. (2018) · Journal of Virology · doi:10.1128/jvi.00116-18 · Cited by 154
Self-citationBailey-Elkin, B. A., Knaap, R. C. M., Johnson, G. G. R. J., Dalebout, T. J., Ninaber, D. K., van Kasteren, P. B., Bredenbeek, P. J., Snijder, E. J., Kikkert, M., & Mark, B. L. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.609644 · Cited by 153
MERS-CoV Accessory ORFs Play Key Role for Infection and Pathogenesis
Menachery, V. D., Mitchell, H. D., Cockrell, A. S., Gralinski, L. E., Yount, B. L., Graham, R. L., McAnarney, E. T., Douglas, M. G., Scobey, T., Beall, A. E., et al. (2017) · mBio · doi:10.1128/mbio.00665-17 · Cited by 153
Viral Etiology of Acute Respiratory Infections With Cough in Infancy
Regamey, N., Kaiser, L., Roiha, H. L., Deffernez, C., Kuehni, C. E., Latzin, P., Aebi, C., & Frey, U. (2008) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31815922c8 · Cited by 152
Coronavirus HKU1 Infection in the United States
Esper, F. P., Weibel, C., Ferguson, D. J. P., et al. (2006) · Emerging infectious diseases · doi:10.3201/eid1205.051316 · Cited by 151
Optimizing use of theranostic nanoparticles as a life-saving strategy for treating COVID-19 patients
Itani, R., Tobaiqy, M. A., & Faraj, A. A. (2020) · Theranostics · doi:10.7150/thno.46691 · Cited by 150
Antibody responses to individual proteins of SARS coronavirus and their neutralization activities
Qiu, M., Shi, Y., Guo, Z., Chen, Z., He, R., Chen, R., Zhou, D., Dai, E., Wang, X., Si, B., et al. (2005) · Microbes and Infection · doi:10.1016/j.micinf.2005.02.006 · Cited by 147
Wang, C., Zheng, X., Gai, W., Zhao, Y., Wang, H., Wang, H., Feng, N., Chi, H., Qiu, B., Li, N., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8475 · Cited by 145
Advances in MERS-CoV Vaccines and Therapeutics Based on the Receptor-Binding Domain
Zhou, Y., Yang, Y., Huang, J., Jiang, S., & Du, L. (2019) · Viruses · doi:10.3390/v11010060 · Cited by 143
Self-citationMa, C., Li, Y., Wang, L., Zhao, G., Tao, X., Tseng, C.-T. K., Zhou, Y., Du, L., & Jiang, S. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.02.004 · Cited by 139
Self-citationSerodiagnostics for Severe Acute Respiratory Syndrome–Related Coronavirus 2: A Narrative Review
Cheng, M. P., Yansouni, C. P., Basta, N. E., Desjardins, M., Kanjilal, S., Paquette, K., Caya, C., Semret, M., Quach, C., Libman, M., et al. (2020) · Annals of Internal Medicine · doi:10.7326/m20-2854 · Cited by 139
Jiang, S., Bottazzi, M. E., Du, L., Lustigman, S., Tseng, C.-T. K., Curti, E., Jones, K. M., Zhan, B., & Hotez, P. J. (2012) · Expert Review of Vaccines · doi:10.1586/erv.12.126 · Cited by 137
Self-citationChen, Y.-Q., Rajashankar, K. R., Yang, Y., Agnihothram, S., Liu, C., Lin, Y.-L., Baric, R. S., & Li, F. (2013) · Journal of Virology · doi:10.1128/jvi.01756-13 · Cited by 137
Prospects for a MERS-CoV spike vaccine
Zhou, Y., Jiang, S., & Du, L. (2018) · Expert Review of Vaccines · doi:10.1080/14760584.2018.1506702 · Cited by 136
Self-citationHe, Y., Li, J., Heck, S., Lustigman, S., & Jiang, S. (2006) · Journal of Virology · doi:10.1128/jvi.00083-06 · Cited by 135
Self-citationEmerging Viruses without Borders: The Wuhan Coronavirus
Liu, S., & Saif, L. J. (2020) · Viruses · doi:10.3390/v12020130 · Cited by 132
Ma, C., Wang, L., Tao, X., Zhang, N., Yang, Y., Tseng, C.-T. K., Li, F., Zhou, Y., Jiang, S., & Du, L. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.08.086 · Cited by 131
Self-citationDu, L., Zhao, G., Chan, C. C. S., Sun, S., Chen, M., Liu, Z., Guo, H., He, Y., Zhou, Y., Zheng, B., et al. (2009) · Virology · doi:10.1016/j.virol.2009.07.018 · Cited by 129
Self-citationZhang, N., Channappanavar, R., Ma, C., Wang, L., Tang, J., Garron, T. M., Tao, X., Tasneem, S., Lu, L., Tseng, C.-T. K., et al. (2015) · Cellular and Molecular Immunology · doi:10.1038/cmi.2015.03 · Cited by 128
Self-citationHofmann, H., Simmons, G., Rennekamp, A. J., Chaipan, C., Gramberg, T., Heck, E., Geier, M., Wegele, A., Marzi, A., Bates, P. F., et al. (2006) · Journal of Virology · doi:10.1128/jvi.00560-06 · Cited by 124
Du, L., Tai, W., Yang, Y., Zhao, G., Zhu, Q., Sun, S., Liu, C., Tao, X., Tseng, C.-T. K., Perlman, S. M., et al. (2016) · Nature Communications · doi:10.1038/ncomms13473 · Cited by 124
Self-citationDetection of Coronaviruses in Bats of Various Species in Italy
Lelli, D., Papetti, A., Sabelli, C., Rosti, E., Moreno, A. M., & Boniotti, M. B. (2013) · Viruses · doi:10.3390/v5112679 · Cited by 121
Gerna, G., Percivalle, E., Sarasini, A., Campanini, G., Piralla, A., Rovida, F., Genini, E., Marchi, A., & Baldanti, F. (2007) · Journal of Clinical Virology · doi:10.1016/j.jcv.2006.12.008 · Cited by 121
Immunological characterizations of the nucleocapsid protein based SARS vaccine candidates
Liu, S., Leng, C. H., Lien, S., Chi, H.-Y., HUANG, C., LIN, C., Wu, L., Chen, C., HSIEH, S., & Chong, P. C.-S. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.01.058 · Cited by 120
Chen, W., Du, L., Chag, S., Ma, C., Tricoche, N., Tao, X., Seid, C. A., Hudspeth, E. M., Lustigman, S., Tseng, C.-T. K., et al. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.27464 · Cited by 118
Self-citationHe, Y., Li, J., Li, W., Lustigman, S., Farzan, M., & Jiang, S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.10.6085 · Cited by 118
Self-citationTai, W., Zhao, G., Sun, S., Guo, Y., Wang, Y., Tao, X., Tseng, C.-T. K., Li, F., Jiang, S., Du, L., et al. (2016) · Virology · doi:10.1016/j.virol.2016.10.005 · Cited by 112
Self-citationLan, J., Yao, Y., Deng, Y. L., Chen, H., Lu, G., Wang, W., Bao, L., Deng, W., Wei, Q., Gao, G. F., et al. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.08.031 · Cited by 111
COVID-19 : physiopathologie d’une maladie à plusieurs visages
Bonny, V., Maillard, A., Mousseaux, C., Plaçais, L., & Richier, Q. (2020) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2020.05.003 · Cited by 108
Lau, S. K. P., Zhang, L., Luk, H. K. H., Xiong, L., Peng, X., Li, K. S. M., He, X., Zhao, S., Fan, R. Y. Y., Wong, A. C. P., et al. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy018 · Cited by 106
Vaccines for the prevention against the threat of MERS-CoV
Du, L., Tai, W., Zhou, Y., & Jiang, S. (2016) · Expert Review of Vaccines · doi:10.1586/14760584.2016.1167603 · Cited by 102
Self-citationKapikian, A. Z., James, H. D., Kelly, S. J., Dees, J. H., Turner, H. C., McIntosh, K., Kim, H., Parrott, R. H., Vincent, M. M., & Chanock, R. M. (1969) · The Journal of Infectious Diseases · doi:10.1093/infdis/119.3.282 · Cited by 102
Severance, E. G., Bossis, I., Dickerson, F., Stallings, C. R., Origoni, A. E., Sullens, A., Yolken, R. H., & Viscidi, R. P. (2008) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00124-08 · Cited by 101
Growth and Intracellular Development of a New Respiratory Virus
Hamre, D. M., Kindig, D. A., & Mann, J. (1967) · Journal of Virology · doi:10.1128/jvi.1.4.810-816.1967 · Cited by 96
Immunogenicity of Candidate MERS-CoV DNA Vaccines Based on the Spike Protein
Alamri, S. S., Abbas, A. T., Siddiq, L. A., Alghamdi, A., Sanki, M. A., Al‐Muhanna, M. K., Alhabbab, R. Y., Azhar, E. I., Li, X., & Hashem, A. M. (2017) · Scientific Reports · doi:10.1038/srep44875 · Cited by 93
Tai, W., Wang, Y., Fett, C., Zhao, G., Li, F., Perlman, S. M., Jiang, S., Zhou, Y., & Du, L. (2016) · Journal of Virology · doi:10.1128/jvi.01651-16 · Cited by 92
Self-citationMatoba, Y., Abiko, C., Ikeda, T., Aoki, Y., Suzuki, Y., Yahagi, K., Matsuzaki, Y., Itagaki, T., Katsushima, F., Katsushima, Y., et al. (2014) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.jjid.2014.266 · Cited by 91
Li, J., Ulitzky, L., Silberstein, E., Taylor, D. R., & Viscidi, R. P. (2013) · Viral Immunology · doi:10.1089/vim.2012.0076 · Cited by 89
Adney, D. R., Wang, L., van Doremalen, N., Shi, W., Zhang, Y., Kong, W., Miller, M. R., Bushmaker, T., Scott, D. P., de Wit, E., et al. (2019) · Viruses · doi:10.3390/v11030212 · Cited by 88
He, Y., Zhou, Y., Siddiqui, P., Niu, J., & Jiang, S. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.8.3718-3726.2005 · Cited by 84
Self-citationJiaming, L., Yanfeng, Y., Deng, Y. L., Yawei, H., Linlin, B., Baoying, H., Jinghua, Y., Gao, G. F., Chuan, Q., & Wenjie, T. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.11.064 · Cited by 84
Luo, F., Liao, F., Wang, H., Tang, H.-B., Yang, Z.-Q., & Hou, W. (2018) · Virologica Sinica · doi:10.1007/s12250-018-0009-2 · Cited by 82
SARS CoV subunit vaccine: antibody-mediated neutralisation and enhancement.
Jaume, M., Yip, M., Kam, Y., Cheung, C. Y., Kien, F., Roberts, A., Li, P. H., Dutry, I., Escriou, N., Daëron, M., et al. (2012) · PubMed · Cited by 81
Lan, J., Deng, Y. L., Chen, H., Lu, G., Wang, W., Guo, X., Lu, Z., Gao, G. F., & Tan, W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112602 · Cited by 81
Receptor-binding domain as a target for developing SARS vaccines.
Zhu, X., Liu, Q., Du, L., Lu, L., & Jiang, S. (2013) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2072-1439.2013.06.06 · Cited by 80
Self-citationBoosted expression of the SARS-CoV nucleocapsid protein in tobacco and its immunogenicity in mice
Zheng, N., Xia, R., Yang, C., Yin, B., Yin, L., Duan, C., Liang, L., Guo, H., & Xie, Q. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.05.073 · Cited by 80
Zakhartchouk, A. N., Sharon, C., Satkunarajah, M., Aupérin, T. C., Viswanathan, S., Mutwiri, G., Petric, M., See, R. H., Brunham, R. C., Finlay, B. B., et al. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.06.084 · Cited by 79
Tang, J., Zhang, N., Tao, X., Zhao, G., Guo, Y., Tseng, C.-T. K., Jiang, S., Du, L., & Zhou, Y. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1021527 · Cited by 77
Self-citationOu, X., Guan, H., Qin, B., Mu, Z., Wojdyla, J. A., Wang, M., Dominguez, S. R., Qian, Z., & Cui, S. (2017) · Nature Communications · doi:10.1038/ncomms15216 · Cited by 76
Desforges, M., Desjardins, J., Zhang, C., & Talbot, P. J. (2013) · Journal of Virology · doi:10.1128/jvi.02699-12 · Cited by 71
Engineering a stable CHO cell line for the expression of a MERS-coronavirus vaccine antigen
Nyon, M. P., Du, L., Tseng, C.-T. K., Seid, C. A., Pollet, J. B. K., Naceanceno, K. S., Agrawal, A. S., Algaissi, A. A., Peng, B., Tai, W., et al. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.02.065 · Cited by 69
Self-citationSeroepidemiology of group I human coronaviruses in children
Shao, X., Guo, X., Esper, F. P., Weibel, C., & Kahn, J. S. (2007) · Journal of Clinical Virology · doi:10.1016/j.jcv.2007.08.007 · Cited by 67
Human coronaviruses: A brief review
Myint, S. (1994) · Reviews in Medical Virology · doi:10.1002/rmv.1980040108 · Cited by 64
Mobaraki, K., & Ahmadzadeh, J. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-3987-2 · Cited by 64
Receptor-binding domain-based subunit vaccines against MERS-CoV
Zhang, N., Tang, J., Lu, L., Jiang, S., & Du, L. (2014) · Virus Research · doi:10.1016/j.virusres.2014.11.013 · Cited by 61
Self-citationZeng, F., Chow, K. Y. C., Hon, C.-C., Law, K. M., Yip, C. W., Chan, K. H., Peiris, M. J. S., & Leung, F. C.-C. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.01.166 · Cited by 59
Wang, Y., Tai, W., Yang, J., Zhao, G., Sun, S., Tseng, C.-T. K., Jiang, S., Zhou, Y., Du, L., & Gao, J. (2017) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2017.1296994 · Cited by 56
Self-citationLiu, R., Wu, L.-Z., Huang, B., Huang, J.-L., Zhang, Y.-L., Ke, M.-L., Jun-mei, W., Tan, W.-P., Zhang, R.-H., Chen, H.-K., et al. (2005) · Virus Research · doi:10.1016/j.virusres.2005.02.009 · Cited by 55
Luo, Z., Ang, M. J. Y., Chan, S. Y., Yi, Z., Goh, Y. Y., Yan, S., Tao, J., Liu, K., Li, X., Zhang, H., et al. (2020) · Research · doi:10.34133/2020/6925296 · Cited by 54
Du, L., Zhao, G., Li, L., He, Y., Zhou, Y., Zheng, B., & Jiang, S. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.05.003 · Cited by 50
Self-citationDu, L., Zhao, G., Chan, C. C. S., Li, L., He, Y., Zhou, Y., Zheng, B., & Jiang, S. (2010) · Viral Immunology · doi:10.1089/vim.2009.0090 · Cited by 46
Self-citationDevelopment of subunit vaccines against severe acute respiratory syndrome
Du, L., He, Y., Jiang, S., & Zheng, B.-J. (2008) · Drugs of today · doi:10.1358/dot.2008.44.1.1131830 · Cited by 44
Self-citationMiddle East respiratory syndrome: current status and future prospects for vaccine development
Du, L., & Jiang, S. (2015) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.1092518 · Cited by 43
Self-citationJiang, S., Lu, L., Du, L., & Debnath, A. K. (2012) · Journal of Infection · doi:10.1016/j.jinf.2012.12.003 · Cited by 41
Self-citationGuo, Y., Sun, S., Wang, K., Zhang, S., Zhu, W., & Chen, Z. (2005) · DNA and Cell Biology · doi:10.1089/dna.2005.24.510 · Cited by 38
Veit, S., Jany, S., Fux, R., Sutter, G., & Volz, A. (2018) · Viruses · doi:10.3390/v10120718 · Cited by 38
MERS Coronavirus: An Emerging Zoonotic Virus
Li, F., & Du, L. (2019) · Viruses · doi:10.3390/v11070663 · Cited by 38
Self-citationHe, Y., Li, J., & Jiang, S. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.03.139 · Cited by 35
Self-citationDevelopment of Middle East Respiratory Syndrome Coronavirus vaccines – advances and challenges
Cho, H., Excler, J., Kim, J. H., & Yoon, I. (2017) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2017.1389362 · Cited by 30
Lehmann, C., Wolf, H. J., Xu, J., Zhao, Q., Shao, Y., Motz, M., & Lindner, P. (2008) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2007.12.002 · Cited by 28
Du, L., Ma, C., & Jiang, S. (2013) · Journal of Infection · doi:10.1016/j.jinf.2013.05.002 · Cited by 24
Self-citationYang, Y., Deng, Y. L., Wen, B., Wang, H., Meng, X., Lan, J., Gao, G. F., & Tan, W. (2014) · Viral Immunology · doi:10.1089/vim.2014.0080 · Cited by 24
Detection of Murine Herpesvirus 68 (MHV-68) in Dermacentor reticulatus Ticks
Kúdelová, M., Belvončíková, P., Vrbová, M., Kovaľová, A., Štibrániová, I., Kocáková, P., Slovák, M., Špitalská, E., Lapuníková, B., Matúšková, R., et al. (2015) · Microbial Ecology · doi:10.1007/s00248-015-0622-7 · Cited by 20
Chang, L., Hong, W., Chong, P. C.-S., & WU, S. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.09.011 · Cited by 12
Cited by
Tai, W., He, L., Zhang, X., Pu, J., Voronin, D., Jiang, S., Zhou, Y., & Du, L. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0400-4 · Cited by 1,654
COVID-19 Vaccine: A comprehensive status report
Kaur, S. P., & Gupta, V. (2020) · Virus Research · doi:10.1016/j.virusres.2020.198114 · Cited by 852
Mucosal vaccines — fortifying the frontiers
Lavelle, E. C., & Ward, R. W. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00583-2 · Cited by 752
Immune response, inflammation, and the clinical spectrum of COVID-19
García, L. F. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01441 · Cited by 739
COVID-19 vaccine development and a potential nanomaterial path forward
Shin, M. D., Shukla, S., Chung, Y. H., Beiss, V., Chan, S. K., Ortega-Rivera, O. A., Wirth, D. M., Chen, A., Sack, M., Pokorski, J. K., et al. (2020) · Nature Nanotechnology · doi:10.1038/s41565-020-0737-y · Cited by 659
Metadata
- Authors
- Wang, N., Shang, J., Jiang, S., & Du, L.
- Venue
- Frontiers in Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2020-02-28
- Volume
- 11
- Pages
- 298-298
- ISSN
- 1664-302X (ISSN-L)
- OpenAlex
- W3007257464
- Cited by
- 425
- References
- 164
- FWCI
- 10.99
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.